Global Strategic Alliance & MSA with Image Analysis Group
Filed with ASX · · 4 pages · English
Summary by 6ix AI
Resonance Health Ltd has announced a strategic alliance and master services agreement with Image Analysis Group, a global imaging clinical research organization, to enhance their clinical trial capabilities. The agreement allows Resonance's MRI analysis services to be integrated into IAG's global clinical trial strategies, providing access to a broader imaging infrastructure. This partnership targets high-growth areas such as obesity and metabolic diseases, with a focus on non-invasive imaging technologies. The agreement is non-exclusive and includes an initial term with options for renewal, with revenue dependent on executed work orders.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Resonance Health
- Appendix 4G & Corporate Governance Statement
- FY26 Full Year Results & Investor Webinar
- FY26 Full Year Results & FY27 Guidance Investor Presentation
- Appendix 4E, Full Year Statutory Accounts & Annual Report
- FY26 Full Year Results Webinar
Later from Resonance Health
- Change in Substantial Holding
- AGM Date & Director Nomination Closing Date
- Liver Fibrosis Device - Clinical Trial Results - Webinar
- Notice of Annual General Meeting/Proxy Form
- Trading Halt
Follow Resonance Health into a list and get an email when it puts out news.
Follow Resonance Health